Related Experiment Video
Updated: Sep 9, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Suicide assessment and feasible evidence-based treatments for adolescents living with HIV in Malawi: Protocol for a
Melissa A Stockton1,2, Katherine Waddell3, Steven M Mphonda3
1Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Background:
This pilot trial will investigate the feasibility, acceptability, fidelity, and preliminary efficacy of a combined youth-friendly suicide prevention and problem-solving intervention in reducing suicidal ideation and behaviors in adolescents living with HIV (ALWH) in Malawi.
Methods:
ALWH (N = 60) aged 13-19 who reported suicidal ideation and behaviors will be recruited from 5 health clinics. Participants will be randomized 1:1 either to the Safety Planning and Friendship Bench (SP + FB) (n = 30) or to augmented usual care (n = 30) and followed for 6 months. SP + FB includes 6 individual counseling sessions and 6 bi-monthly peer support group sessions delivered by psychological counselors. Feasibility, acceptability, fidelity, and preliminary efficacy will be assessed at 6-weeks and 3- and 6-month study visits and compared across the 2 study arms.
Discussion:
The results of this study will provide insights into the feasibility, acceptability, fidelity, and preliminary efficacy of the combined SP + FB for reducing chronic and acute suicidality in ALWH compared to standard of care. This pilot study will lay the groundwork to test the SP + FB in a large-scale cluster randomized controlled trial to improve suicide prevention resources and interventions for ALWH in Malawi. The findings of the study will add to a critical body of research aiming to implement feasible, acceptable, and effective suicide prevention interventions as part of adolescent HIV care in low-resource settings.
Trial Registeration:
ClinicalTrials.gov: NCT06770101.

